Noncancer pain management in seriously ill older adults: Practical considerations with opioid use

Clinical Geriatrics

Volumn 20, Issue 8, 2012, Pages 24-31

  Malec, Monica ^a   Knoebel, Randall W ^a   Shega, Joseph W ^a   Reid, Manny Carrington ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Noncancer pain; Opioid use in the elderly; Pain control; Pain management

Indexed keywords

ACETYLSALICYLIC ACID; BUPRENORPHINE; CODEINE; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; TRAMADOL;

ACUTE LIVER FAILURE; AGE DISTRIBUTION; AGING; ANALGESIA; ANALGESIC ACTIVITY; ANOREXIA; ANXIETY; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFUSION; CONSTIPATION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COST; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG USE; ELDERLY CARE; HEADACHE; HEARTBURN; HEPATITIS; HUMAN; INDIGESTION; KIDNEY CLEARANCE; KIDNEY FUNCTION; LIVER CANCER; LIVER CIRRHOSIS; LIVER CLEARANCE; LIVER DYSFUNCTION; LIVER INJURY; NAUSEA; NEUROPATHIC PAIN; NONCANCER PAIN; PAIN; PAIN ASSESSMENT; PLASMA HALF LIFE; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; SEIZURE THRESHOLD; SELF REPORT; SIDE EFFECT; SINGLE DRUG DOSE; STEADY STATE; SWEATING; VOMITING; XEROSTOMIA;

EID: 84866328882     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Maxwell CJ, Dalby DM, Slater M, et al. The prevalence and management of current daily pain among older home care clients. Pain. 2008;138(1):208-216.
2. Jakobsson U, Klevsgard R, Westergren A, Hallberg IR. Old people in pain: a comparative study. J Pain Symptom Manage. 2003;26(1):625-636. (Pubitemid 36802286)
3. Smith AK, Cenzer IS, Knight SJ, et al. The epidemiology of pain during the last 2 years of life. Ann Intern Med. 2010;153(9):563-569.
4. Laiho K, Tuohimehto J, Tilvis R. Prevalence of rheumatoid arthritis and musculoskeletal disease in the elderly population. Rheumatol Int. 2001;20(3):85-87. (Pubitemid 32250117)
5. Bianchi ML, Orsini MR, Saraifoger S, Ortolani S, Radelli G, Betti S. Quality of life in post-menopausal osteoporosis. Health Qual Life Outcomes. 2005;3:78.
6. Kimberlin DK, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007;356(13):1338-1343. (Pubitemid 46513299)
7. Centers for Disease Control and Prevention. Arthritis-related statistics. www.cdc.gov/arthritis/data-statistics/arthritis-related-stats.htm#1. Accessed July 31, 2012.
8. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50(suppl 6):S205-224.
9. Weiner DK, Haggerty CL, Kritchvesky SB, et al. How does low back pain impact physical function in independent, well-functioning older adults? Evidence from the Health ABC Cohort and implications for the future. Pain Med. 2003;4(4):311-320.
10. Bosley BN, Weiner DK, Rudy TE, Granieri E. Is chronic nonmalignant pain associated with decreased appetite in older adults? Preliminary evidence. J Am Geriatr Soc. 2004;52:247-251. (Pubitemid 38233488)
11. Shega JW, Dale W, Andrews M, Paice J, Rockwood K, Weiner DK. Persistent pain and frailty: a case for pain homeostenosis? J Amer Geriatr Soc. 2012;60(1): 113-117.
12. Sawyer P, Bodner EV, Ritchie CS, Allman RM. Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother. 2006;4(4):316-324. (Pubitemid 46211184)
13. Won AB, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc. 2004;52(6):867-874. (Pubitemid 38789056)
14. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology [published correction appears in JAMA. 1999;281(2):136]. JAMA. 1998;279(23):1877-1882.
15. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimeters? Pain. 1997;72(1-2):95-97. (Pubitemid 27321906)
16. PainKnowledge.org. Iowa Pain Thermometer Scale. www.painknowledge.org/ physiciantools/Pain-Thermometer/Iowa%20Pain%20Thermometer%20Scale. pdf. Accessed July 31, 2012.
17. International Association for the Study of Pain. Faces Pain Scale-Revised.www.iasp-pain.org/Content/NavigationMenu/GeneralResourceLinks/ FacesPain- ScaleRevised/default.htm. Accessed July 31, 2012.
18. Herr K. Pain assessment strategies in older patients. J Pain. 2011;12(3):S3-S13.
19. American Medical Directors Association. Pain Assessment in Advanced Dementia (PAINAD) Scale. http://web.missouri.edu/~proste/tool/cog/painad.pdf. Accessed July 31, 2012.
20. Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC). http://www.rgpc.ca/best/PAIN%20Best%20Practices%20-%20ML%20 Vanderhorst%20(June%2007)/PACSLAC.pdf. July 31, 2012.
21. Papaleontiou M, Henderson CR Jr, Turner BJ, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2010;58(7):1353-1369.
22. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-1334. (Pubitemid 40411499)
23. Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic noncancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physicians. 2008;11(suppl 2):S5-S62. (Pubitemid 351682078)
24. Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc. 2010;58(9):1664-1670.
25. Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010;170(22):1979-1986.
26. Katz KD. Tramadol is an opioid. J Med Toxicol. 2008;4(2):145.
27. Papaeleontiou M, Henderson CR, Turner BT, et al. Outcomes associated with opioid use in the treatment of chronic non-cancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2010;58(7):1353-1369.
28. Smith H. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613-624.
29. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11(suppl 2):S133-S153. (Pubitemid 351682083)
30. Matzke GR, Chan GLC, Abraham PA. Codeine dosage in renal failure [letter]. Clin Pharm. 1986;5(1):15-16.
31. Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, and oxycodone). Pain Pract. 2008;8(4):287-313.
32. Quigley C, Wiffen P. A systematic review of hydromorphone in acute and chronic pain. J Pain Symptom Manage. 2003;25(2):169-178.
33. Kalso E. Oxycodone. J Pain Symptom Manage. 2005;29(suppl 5):S47-S56. (Pubitemid 40720246)
34. Heiskanen T, Matzke S, Haakana S, Gregov M, Vuori E, Kalso E. Transdermal fentanyl in cachectic cancer patients. Pain. 2009;144(1-2):218-222.
35. Lugo RA, Satterfield KL, Kern SE. Phamacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13-24.
36. Vadivelu N, Hines RL. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging. 1998;3(3):421-430.
37. Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627-632.
38. Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practicea post-marketing surveillance study in 13,179 patients. Curr Med Res Opin. 2005; 21(8):1147-1156. (Pubitemid 41140716)
39. Gupta DK, Avram MJ. Rational opioid dosing in the elderly: dose and dosing intervals when initiating opioid therapy. Clin Pharmacol Ther. 2012;91(2):339-343.
40. Rauck RL. What is the case for prescribing long-acting over short-acting opioids for patients with chronic pain? A critical review. Pain Pract. 2009;9(6):468-479.
41. Schwartz JB. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther. 2007;82(1):87-96. (Pubitemid 46944201)
42. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331-1346.
43. Tumer N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol. 1992;32:271-302.
44. Davies DF, Shock NW. Age changes in glomerular filtration rate, effect of venal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950;29(5):496-507.
45. Verbeeck RK. Pharmacokinetics and dose adjustments in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64(12):1147-1161.
46. Murtagh FE, Chai MO, Donohoe P, Edmonds PM, Higginson IJ. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother. 2007;21(2):5-16. (Pubitemid 47366087)
47. Pham PC, Toscano E, Pham PM, Pham PA, Pham S, Pham PT. Pain management in patients with chronic kidney disease. NDT Plus. 2009;2(2):111-118.
48. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9): 2542-2554. (Pubitemid 32391226)